Over the Counter (OTC) Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Pill Type (Progestin Pills and Combination Pills), By Category (Generic and Branded), By Distribution Channel (Offline and Online), By Region and Competition, 2019-2029F

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

Forecast Period

2025-2029

Market Size (2023)

USD 16.09 Billion

Market Size (2029)

USD 26.20 Billion

CAGR (2024-2029)

8.54%

Fastest Growing Segment

Combination Pills

Largest Market

North America

Market Overview

Global Over the Counter (OTC) Contraceptive Pills Market stood at USDb 16.09 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.54% through 2029. The Global Over the Counter (OTC) Contraceptive Pills Market refers to the economic sector that deals with the sale and distribution of birth control pills available directly to consumers without a prescription. These pills contain hormones that prevent pregnancy and are used worldwide as a method of contraception. The market is characterized by numerous factors that influence its growth, such as government policies, societal acceptance, public awareness of accessibility, and advancements in pharmaceutical technology. With an increasing focus on reproductive health and rights, this market is poised to expand as it responds to the demand for convenient and private access to birth control methods.

Key Market Drivers

Increased Awareness & Education

One of the most important factors influencing Over the Counter (OTC) Contraceptive Pills market is increased awareness and education. Through awareness campaigns and educational programs, more women become aware of the different types of contraception available to them. As a result, they become more aware of the benefits and significance of contraception in preventing unwanted pregnancies and improving overall health. Oral contraceptives are the most popular form of reversible contraceptives in the U.S. According to 2017–2019 National Survey of Family Growth data, 65% of women aged 15 to 49 reported using contraception. Female sterilization accounted for 18.1% of all contraceptive use, while oral contraceptive Pills accounted for 14.3% of all use. Long-acting reversible contraception accounted for 10.4% of all use, while the external condom accounted for 8.4%.

By educating women about contraception methods, including Over the Counter (OTC) Contraceptive Pills, myths and misperceptions about birth control are reduced, leading to less stigma and more acceptance. As more women learn about different contraceptive methods, they’re more likely to see OTC Pills as a good option, especially for women who want to remain in control of their reproductive choices without frequent doctor visits.

In addition, women are better able to make informed decisions about their reproductive health because healthcare providers and organizations provide comprehensive educational campaigns. Women learn about the effectiveness of OTC contraceptives, side effects and how to use them correctly, allowing them to choose the best option based on their needs and preferences.  The effects of increased awareness also extend to social attitudes. With more open and supportive conversations about family planning, women feel more confident to talk about contraception and access methods. This shift in culture reduces obstacles to taking over-the-counter contraceptive Pills and promotes responsible use.

To sum up, the Over the Counter (OTC) Contraceptive Pills market is positively impacted by increased awareness and education, which allows women to make informed reproductive health decisions. As awareness of family planning increases, more women see and accept OTC contraception Pills as an easy and effective way to responsibly manage their reproductive choices. This results in boosting the demand for Over the Counter (OTC) market increases in the forecast period.

Increasing Culture Shifts & Attitudes

The OTC contraceptive pill market is driven by cultural shifts and attitudes. As social norms change, conversations about reproductive health become more inclusive and less stigmatized. This cultural shift creates a space where women feel more confident and empowered to explore various forms of contraception, including Over the Counter (OTC) Contraceptive Pills. As cultural attitudes change, the image of family planning changes from one that is seen as taboo to one that is embraced and supported.

In addition, as women and men talk more openly about their reproductive options, the value of affordable and easy-to-use methods of contraception is becoming increasingly clear. OTC methods of contraception, with their convenience and discreet use, respond to the changing culture and appeal to people who value autonomy and decision-making when it comes to family planning. A survey last year by KFF (Kaiser Family Foundation), found that more than four-in-five women of reproductive age say they prefer an OTC pill, mainly because it’s easier to take. Almost 40 percent said they’d be likely to use the product. The survey found that women who are already taking a birth control pill, women who don’t have health insurance and women who are Hispanic were the most likely to use an OTC pill.

Also, as cultural beliefs and practices focus more on gender roles and women’s empowerment, there’s a growing need for contraception options that allow women to make better decisions about their bodies. OTC Pills empower women to take control of their reproductive health, without having to go to the doctor or rely on a partner to access birth control. Cultural attitudes also affect healthcare providers’ behavior, prompting them to provide more information about over the counter (OTC) contraceptives. This makes OTC Pills more accessible because doctors and pharmacists support their use.

The market for over the counter (OTC) contraceptive Pills is expected to continue to grow as culture and attitudes change. Society’s acceptance and support of effective family planning practices increases the need for affordable and effective contraceptives, which in turn increases the demand for OTC Pills among women who want more control over their fertility. As a result, demand for Over the Counter (OTC) market increases in the forecast period.

Government Supporting Policies and Regulations

Government supporting policies are one of the most important factors driving the OTC pill market. When the government revises regulations to allow prescription-only sale of some contraceptive Pills, it significantly improves the accessibility and availability of OTC Pills. By eliminating the prescription hurdle, women can easily access OTC Pills, which promotes responsible family planning, and reduces the number of unwanted pregnancies.

Supportive policies emphasize the importance of women’s reproductive health and encourage healthcare professionals and pharmacists to promote and educate patients on over the counter (OTC) contraceptive options. The United States Food and Drug Administration (FDA) has granted a marketing authorization for Opill, a nonprescription oral contraceptive pill containing norgestrel, for the prevention of pregnancy. Opill is the first FDA-approved daily oral contraceptive pill for use in the United States without a prescription. The approval of this oral contraceptive pill containing progestin only allows consumers to buy oral contraceptive medicines without a prescription at pharmacies, convenience stores, grocery stores, and online pharmacies.

These policies also help to reduce the cost of contraceptive consultations, which makes birth control more accessible and attractive to the public. All in all, government support creates an environment conducive to the development of the over the counter (OTC) pill market, allowing women to make their own reproductive choices while supporting public health initiatives and family planning. This upsurges the growth of Over the Counter (OTC) Contraceptive Pills market in the coming years.

Surge In E-Commerce & Online Pharmacies

The surge in e-commerce and online pharmacies is playing a significant role in increasing the demand for Over-the-Counter (OTC) contraceptive pills globally. With the rise of digital platforms, consumers now have convenient access to a wide range of contraceptive products without the need for a prescription or in-person visit to a healthcare provider. Online pharmacies offer discreet and hassle-free shopping experiences, allowing individuals to browse, purchase, and have contraceptive pills delivered directly to their doorsteps. The anonymity provided by online platforms appeals to consumers who may feel uncomfortable discussing contraception in traditional healthcare settings. The availability of informational resources and customer reviews on e-commerce websites empowers individuals to make informed decisions about their contraceptive options. The convenience of online shopping and the ability to compare prices across different brands and formulations make OTC contraceptive pills more accessible and affordable to a broader audience. As a result, the surge in e-commerce and online pharmacies is driving the demand for OTC contraceptive pills globally, as individuals seek convenient and discreet solutions for family planning and reproductive health management.


Download Free Sample Report

Key Market Challenges

Counterfeit Products

The presence of counterfeit products in the market is a significant factor contributing to the decrease in demand for Over-the-Counter (OTC) contraceptive pills globally. Counterfeit contraceptive pills often mimic the appearance of genuine products, making it difficult for consumers to distinguish between authentic and fake medications. However, counterfeit pills may contain incorrect dosages, ineffective ingredients, or harmful substances, posing serious risks to users' health and safety. The proliferation of counterfeit products erodes consumer trust in OTC contraceptive pills, leading individuals to hesitate or refrain from purchasing these medications altogether out of fear of unknowingly consuming counterfeit pills. The negative publicity surrounding counterfeit incidents can tarnish the reputation of legitimate brands and the entire OTC contraceptive market, further dampening demand. The prevalence of counterfeit products may prompt regulatory agencies to impose stricter regulations or restrictions on OTC contraceptive pills, limiting their availability and accessibility to consumers. Efforts to combat counterfeit medications through enhanced regulatory oversight, enforcement measures, and consumer education campaigns are essential to mitigate the impact of counterfeit products on the demand for OTC contraceptive pills and ensure the safety and well-being of consumers globally.

Pricing Pressures

Pricing pressures are exerting a significant downward force on the demand for Over-the-Counter (OTC) contraceptive pills globally. While OTC contraceptive pills offer convenience and accessibility compared to prescription alternatives, their affordability remains a crucial factor influencing consumer purchasing decisions. However, the pricing of OTC contraceptive pills can vary widely depending on factors such as brand, formulation, packaging size, and distribution channel. In competitive markets, pricing pressures often drive manufacturers to lower prices to attract consumers, resulting in thinner profit margins for companies and potentially compromising product quality or marketing efforts. Conversely, in regions where OTC contraceptive pills are subject to high markups or taxes, the resulting higher prices may deter cost-conscious consumers from purchasing these products. Pricing pressures can exacerbate disparities in access to contraception, particularly for individuals with limited financial resources or inadequate insurance coverage. As a result, the prevalence of pricing pressures is decreasing the demand for OTC contraceptive pills globally, underscoring the need for affordable and accessible family planning options to ensure universal access to reproductive healthcare. Efforts to address pricing pressures through pricing reforms, subsidies, or cost-sharing arrangements are essential to alleviate financial barriers and stimulate demand for OTC contraceptive pills, improving reproductive health outcomes for individuals worldwide.

Key Market Trends

Continuous Research & The Development of New Products

Continuous research and the development of new products in the field of contraceptives are significantly increasing the demand for Over-the-Counter (OTC) contraceptive pills globally. As researchers strive to improve contraceptive options, innovations in formulation, delivery methods, and hormonal compositions are enhancing the efficacy, safety, and user-friendliness of contraceptive pills. New products offer benefits such as reduced side effects, increased convenience, and improved compliance, addressing the diverse needs and preferences of users. Advancements in contraceptive technology are expanding the range of available options, including extended-cycle pills, low-dose formulations, and non-hormonal alternatives, providing individuals with more choices to suit their individual circumstances and health concerns. Continuous research into contraceptive mechanisms and modes of action fosters confidence in the effectiveness and reliability of OTC contraceptive pills among consumers. The introduction of new products stimulates market competition, prompting existing brands to innovate and improve their offerings to remain competitive. Consequently, continuous research and the development of new products are driving the demand for OTC contraceptive pills globally, as individuals seek access to safe, effective, and convenient options for family planning and reproductive health management.

Increasing Prevalence of Online Consultation Services & Telemedicine

The increasing prevalence of online consultation services and telemedicine is significantly driving the demand for Over-the-Counter (OTC) contraceptive pills globally. With the rise of digital healthcare platforms, individuals now have easier access to virtual consultations with healthcare providers, allowing them to discuss their contraceptive needs and obtain prescriptions remotely. Telemedicine offers a convenient and discreet alternative to traditional in-person visits, particularly for individuals who may feel uncomfortable discussing reproductive health in face-to-face settings. The availability of online consultation services expands access to healthcare for individuals in underserved or remote areas, where healthcare facilities may be limited. Telemedicine enables healthcare providers to prescribe OTC contraceptive pills based on remote consultations, empowering individuals to access contraception without the need for physical appointments. Online pharmacies and e-commerce platforms facilitate the purchase and delivery of OTC contraceptive pills following virtual consultations, further streamlining the process for consumers. As a result, the increasing prevalence of online consultation services and telemedicine is driving the demand for OTC contraceptive pills globally, as individuals seek accessible, convenient, and confidential solutions for family planning and reproductive health management.

Segmental Insights

Pill Type Insights

Based on the Pill Type, in the global Over the Counter (OTC) Contraceptive Pills Market, combination pills, which contain both estrogen and progestin, have traditionally dominated due to their higher efficacy rates and added benefits. These combination pills not only provide effective contraception but also offer advantages such as regulation of menstrual cycles and reduction of menstrual cramps, providing women with added comfort and convenience.

However, progestin-only pills are gaining popularity in recent years, especially among women who cannot tolerate estrogens or who are breast-feeding. These pills present fewer risks for certain groups of women, making them a suitable alternative for those seeking contraception without the potential side effects associated with estrogen. With their increasing acceptance, progestin-only pills are becoming an important option in the contraceptive market, offering diverse choices and ensuring that women can find a method that suits their individual needs and preferences.

Category Insights

Based on the Category segment, in the global Over the Counter (OTC) Contraceptive Pills market, branded options have traditionally maintained a dominant position. This is attributed to the trust consumers place in established pharmaceutical brands, which invest heavily in research, development, and marketing. However, the landscape is evolving as generic versions, offering similar efficacy at a reduced cost, begin to gain traction. This shift is driven by increasing cost-sensitivity among consumers and the growing number of retailers and governments promoting generic medications to curb healthcare expenditures.

As consumers become more informed about their healthcare choices, they are increasingly seeking affordable alternatives without compromising on quality. Generic versions of OTC contraceptive pills offer a compelling solution, providing the same level of effectiveness as their branded counterparts but at a more affordable price point. This affordability factor plays a significant role in addressing the cost-sensitivity among consumers, particularly in regions where access to affordable healthcare is a concern.

The growing number of retailers and governments advocating for the use of generic medications further accelerates the adoption of these alternatives. Retailers are recognizing the demand for cost-effective options and are expanding their product offerings to include generic versions of OTC contraceptive pills. Governments, on the other hand, are actively promoting the use of generic medications as part of their healthcare cost-cutting initiatives. As the market continues to evolve, it is expected that the competition between branded and generic options in the OTC contraceptive pills market will intensify. Branded options will need to adapt to changing consumer preferences and find innovative ways to differentiate themselves from their generic counterparts. On the other hand, generic manufacturers will need to maintain their focus on quality and affordability to gain a larger market share.


Download Free Sample Report

Regional Insights

The Global Over the Counter (OTC) Contraceptive Pills Market has been primarily dominated by the North American region. This dominance can be attributed to several key factors that contribute to the region's success in this market segment. North America boasts a well-established healthcare infrastructure, ensuring that individuals have easy access to healthcare services and resources. This facilitates the availability and distribution of contraceptive pills, making them readily accessible to the population. The high level of awareness regarding sexual health in North America plays a significant role in the market's growth. The region has made significant strides in promoting sexual health education and raising awareness about the importance of contraception. This has led to a more informed population, resulting in a higher demand for contraceptive options, including over the counter pills.

The availability of a wide variety of contraceptive options in North America has contributed to its market dominance. The region offers a range of choices to cater to different preferences and needs, allowing individuals to find the most suitable contraceptive method for them. This diverse range of options further drives the market's growth, as it ensures that individuals have access to a comprehensive selection of products. Initiatives and regulations in North America have been instrumental in supporting and promoting the accessibility of contraception. The region has implemented policies and programs that aim to remove barriers and improve access to contraceptive methods, including over the counter pills. These initiatives have created a favorable environment for the market's growth by ensuring that individuals have easy access to the contraceptive options they need.

Recent Developments

  • In July 2023, Perrigo Company plc, a prominent provider of Consumer Self-Care Products, made an announcement regarding the U.S. Food and Drug Administration (FDA) approval of Opill®. This progestin-only daily oral contraceptive has been approved for over-the-counter (OTC) use for all age groups, marking a significant milestone. Opill® is the first-ever birth control pill to be available over the counter in the United States.

Key Market Players

  • Mylan N.V.
  • The Pill club
  • Nurx Inc.
  • Everly Well, Inc.
  • Letsgetchecked Inc.
  • Uqora, Inc.
  • Hims & Hers Health, Inc.
  • LMND Medical Group, Inc.
  • Perrigo Company plc
  • HRA Pharma America Inc.

 By Pill Type

By Category

By Distribution Channel

By Region

• Progestin Pills

• Combination Pills

 

• Generic

• Branded

• Offline

• Online

• North America

• Europe

• Asia Pacific

• South America

• Middle East & Africa


Report Scope:

In this report, the Global Over the Counter (OTC) Contraceptive Pills Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Over the Counter (OTC) Contraceptive Pills Market, By Pill Type:

o   Progestin Pills

o   Combination Pills

  • Over the Counter (OTC) Contraceptive Pills Market, By Category:

o   Generic

o   Branded

  • Over the Counter (OTC) Contraceptive Pills Market, By Distribution Channel:

o   Offline

o   Online

  • Over the Counter (OTC) Contraceptive Pills Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over the Counter (OTC) Contraceptive Pills Market.

Available Customizations:

Global Over the Counter (OTC) Contraceptive Pills market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Over the Counter (OTC) Contraceptive Pills Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the study

2.2.  Baseline methodology

2.3.  Key industry partners

2.4.  Major association and secondary sources

2.5.  Forecasting methodology

2.6.  Data triangulation & validation

2.7.  Assumptions and limitations

3.    Impact Of Covid-19 On Global Over the Counter (OTC) Contraceptive Pills Market

4.    Executive Summary

4.1.  Overview of the market

4.2.  Overview of key market segmentations

4.3.  Overview of key market players

4.4.  Overview of key regions/countries

4.5.  Overview of market drivers, challenges, trends

5.    Voice of Customer

6.    Global Over the Counter (OTC) Contraceptive Pills Market Outlook

6.1.  Market Size & Forecast

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Pill Type (Progestin Pills and Combination Pills)

6.2.2.    By Category (Generic and Branded)

6.2.3.    By Distribution Channel (Offline and Online)

6.2.4.    By Region

6.2.5.    By Company (2023)

6.3.  Market Map

7.    North America Over the Counter (OTC) Contraceptive Pills Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Pill Type

7.2.2.    By Category

7.2.3.    By Distribution Channel

7.2.4.    By Country

7.3.  North America: Country Analysis

7.3.1.    United States Over the Counter (OTC) Contraceptive Pills Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Pill Type

7.3.1.2.2.           By Category

7.3.1.2.3.           By Distribution Channel

7.3.2.    Canada Over the Counter (OTC) Contraceptive Pills Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Pill Type

7.3.2.2.2.           By Category

7.3.2.2.3.           By Distribution Channel

7.3.3.    Mexico Over the Counter (OTC) Contraceptive Pills Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Pill Type

7.3.3.2.2.           By Category

7.3.3.2.3.           By Distribution Channel

8.    Europe Over the Counter (OTC) Contraceptive Pills Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Pill Type

8.2.2.    By Category

8.2.3.    By Distribution Channel

8.2.4.    By Country

8.3.  Europe: Country Analysis

8.3.1.    Germany Over the Counter (OTC) Contraceptive Pills Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Pill Type

8.3.1.2.2.           By Category

8.3.1.2.3.           By Distribution Channel

8.3.2.    Italy Over the Counter (OTC) Contraceptive Pills Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Pill Type

8.3.2.2.2.           By Category

8.3.2.2.3.           By Distribution Channel

8.3.3.    France Over the Counter (OTC) Contraceptive Pills Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Pill Type

8.3.3.2.2.           By Category

8.3.3.2.3.           By Distribution Channel

8.3.4.    Spain Over the Counter (OTC) Contraceptive Pills Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Pill Type

8.3.4.2.2.           By Category

8.3.4.2.3.           By Distribution Channel

8.3.5.    United Kingdom Over the Counter (OTC) Contraceptive Pills Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Pill Type

8.3.5.2.2.           By Category

8.3.5.2.3.           By Distribution Channel 

9.    Asia-Pacific Over the Counter (OTC) Contraceptive Pills Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Pill Type

9.2.2.    By Category

9.2.3.    By Distribution Channel

9.2.4.    By Country

9.3.  Asia Pacific: Country Analysis

9.3.1.    China Over the Counter (OTC) Contraceptive Pills Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Pill Type

9.3.1.2.2.           By Category

9.3.1.2.3.           By Distribution Channel

9.3.2.    Japan Over the Counter (OTC) Contraceptive Pills Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Pill Type

9.3.2.2.2.           By Category

9.3.2.2.3.           By Distribution Channel

9.3.3.    India Over the Counter (OTC) Contraceptive Pills Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Pill Type

9.3.3.2.2.           By Category

9.3.3.2.3.           By Distribution Channel

9.3.4.    Australia Over the Counter (OTC) Contraceptive Pills Market Outlook

9.3.4.1.        Market Size & Forecast

9.3.4.1.1.           By Value

9.3.4.2.        Market Share & Forecast

9.3.4.2.1.           By Pill Type

9.3.4.2.2.           By Category

9.3.4.2.3.           By Distribution Channel

9.3.5.    South Korea Over the Counter (OTC) Contraceptive Pills Market Outlook

9.3.5.1.        Market Size & Forecast

9.3.5.1.1.           By Value

9.3.5.2.        Market Share & Forecast

9.3.5.2.1.           By Pill Type

9.3.5.2.2.           By Category

9.3.5.2.3.           By Distribution Channel

10. Middle East and Africa Over the Counter (OTC) Contraceptive Pills Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Pill Type

10.2.2. By Category

10.2.3. By Distribution Channel

10.2.4. By Country

10.3.             Middle East and Africa: Country Analysis

10.3.1. UAE Over the Counter (OTC) Contraceptive Pills Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Pill Type

10.3.1.2.2.         By Category

10.3.1.2.3.         By Distribution Channel

10.3.2. Saudi Arabia Over the Counter (OTC) Contraceptive Pills Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Pill Type

10.3.2.2.2.         By Category

10.3.2.2.3.         By Distribution Channel

10.3.3. South Africa Over the Counter (OTC) Contraceptive Pills Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Pill Type

10.3.3.2.2.         By Category

10.3.3.2.3.         By Distribution Channel

11. South America Over the Counter (OTC) Contraceptive Pills Market Outlook

11.1.             Market Size & Forecast        

11.1.1. By Value

11.2.             Market Share & Forecast

11.2.1. By Pill Type

11.2.2. By Category

11.2.3. By Distribution Channel

11.2.4. By Country

11.3.             South America: Country Analysis

11.3.1. Brazil Over the Counter (OTC) Contraceptive Pills Market Outlook

11.3.1.1.     Market Size & Forecast

11.3.1.1.1.         By Value

11.3.1.2.     Market Share & Forecast

11.3.1.2.1.         By Pill Type

11.3.1.2.2.         By Category

11.3.1.2.3.         By Distribution Channel

11.3.2. Argentina Over the Counter (OTC) Contraceptive Pills Market Outlook

11.3.2.1.     Market Size & Forecast

11.3.2.1.1.         By Value

11.3.2.2.     Market Share & Forecast

11.3.2.2.1.         By Pill Type

11.3.2.2.2.         By Category

11.3.2.2.3.         By Distribution Channel

11.3.3. Colombia Over the Counter (OTC) Contraceptive Pills Market Outlook

11.3.3.1.     Market Size & Forecast

11.3.3.1.1.         By Value

11.3.3.2.     Market Share & Forecast

11.3.3.2.1.         By Pill Type

11.3.3.2.2.         By Category

11.3.3.2.3.         By Distribution Channel

12. Market Dynamics

12.1.             Drivers

12.2.             Challenges

13. Market Trends & Developments

13.1.             Merger & Acquisition (If Any)

13.2.             Product Launches (If Any)

13.3.             Recent Developments

14. Global Over the Counter (OTC) Contraceptive Pills Market: SWOT Analysis

15. Pestle Analysis

16. Porter’s Five Forces Analysis

16.1.             Competition in the Industry

16.2.             Potential of New Entrants

16.3.             Power of Suppliers

16.4.             Power of Customers

16.5.             Threat of Substitute Products

17. Competitive Landscape

17.1.             Mylan N.V.

17.1.1. Business Overview

17.1.2. Company Snapshot

17.1.3. Products & Services

17.1.4. Financials (As Reported)

17.1.5. Recent Developments

17.1.6. Key Personnel Details

17.1.7. SWOT Analysis

17.2.               The Pill club

17.3.               Nurx Inc.

17.4.               Everly Well, Inc.

17.5.               Letsgetchecked Inc.

17.6.               Uqora, Inc.

17.7.               Hims & Hers Health, Inc.

17.8.               LMND Medical Group, Inc.

17.9.               Perrigo Company plc

17.10.            HRA Pharma America Inc.

18. Strategic Recommendations

19. About Us & Disclaimer

Figures and Tables

Frequently asked questions

down-arrow

The market CAGR of the Global Over the Counter (OTC) Contraceptive Pills Market is estimated to be 8.54% in 2024-2029.

down-arrow

Branded options have traditionally dominated the global OTC Contraceptive Pills market, benefiting from consumer trust and extensive investments in research and marketing.

down-arrow

The North American region has emerged as the dominant player in the Global Over the Counter (OTC) Contraceptive Pills Market, owing to factors such as a robust healthcare infrastructure, high awareness of sexual health, and a wide range of contraceptive options.

down-arrow

Government supporting policies & regulations and surge in e-commerce & online pharmacies are the major drivers for the Global Over the Counter (OTC) Contraceptive Pills Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Over the Counter (OTC) Contraceptive Pills Market to Grow at 8.54% CAGR through 2029

Apr, 2024

Continuous research & the development of new products and increasing prevalence of online consultation services & telemedicine is expected to drive the Global Over the Counter (OTC) Contraceptive Pil

Why Choose Us